← Latest News · 2026-10-28 edition
US Bans Imports from BGI Genomics and MGI Tech Over Forced Labor Concerns
The U.S. has banned imports from BGI Genomics and MGI Tech due to alleged forced labor ties in Xinjiang. This action highlights ongoing U.S.-China tensions over human rights issues.
The United States has implemented a ban on imports from BGI Genomics and MGI Tech, citing concerns over their alleged involvement in forced labor practices in the Xinjiang region. This decision was announced by U.S. authorities, who have been increasingly scrutinizing companies with operations linked to human rights abuses in China. The ban is part of broader efforts to address and mitigate the use of forced labor in global supply chains.
This move is significant as it underscores the ongoing tensions between the U.S. and China regarding human rights issues. The Xinjiang region has been a focal point of international criticism due to reports of forced labor and other human rights violations. By targeting companies like BGI Genomics and MGI Tech, the U.S. aims to exert pressure on Chinese entities to comply with international labor standards.
According to Reuters, the U.S. government has been actively working to prevent products made with forced labor from entering its markets. This latest action reflects a continued commitment to enforcing trade policies that prioritize ethical sourcing and human rights. The ban on BGI Genomics and MGI Tech is expected to have implications for their business operations and could influence other companies with ties to the region to reassess their supply chain practices.
Sources
This article was generated by AI based on public information and is for reference only. It does not constitute investment advice.